Table 3. Multivariable stepwise regression for days to first received prescription.

Characteristics	Antidepressants				Anxiolytics				Antipsychotics				Prazosin
	Days to first Rx 46.97 ± 63.97				Days to first Rx 73.42 ± 82.86				Days to first Rx 83.35 ± 91.00				Days to first Rx 82.56 ± 89.94
	B	SE	β	P	B	SE	β	P	B	SE	β	P	B	SE	β	P
Female (ref: male)	NS				NS				NS				NS
Ethnicity (ref White)
Black	NS				NS				NS				NS
Hispanic	NS				− 6.79	2.66	− 0.03	0.011	NS				− 8.09	4.01	− 0.04	0.37
Other/unknown	NS				NS				NS				NS
Asian	NS				NS				NS				NS
Married (ref: not married)	NS				NS				NS				NS
Urban living (ref: rural)	3.70	0.78	0.03	<0.001	NS				NS				NS
Diagnosis (ref: without indicated diagnosis)
Schizophrenia					NS				− 25.73	7.69	− 0.04	<0.001	55.76	17.17	0.05	0.001
Other psychosis					NS				− 12.13	4.65	− 0.03	0.009	NS
Bipolar	7.60	2.14	0.02	<0.001	NS				NS				NS
Anxiety disorder	4.19	0.82	0.03	<0.001	NS				9.90	2.37	0.05	<0.001	7.03	3.41	0.04	0.039
Major depression	− 4.19	0.89	− 0.03	<0.001	NS				6.79	2.45	0.03	0.006	11.99	3.50	0.06	0.001
Other depression					7.76	2.06	0.05	<0.001	13.12	2.24	0.07	<0.001	11.67	3.14	0.06	<0.001
Alcohol use disorder	− 3.01	1.06	− 0.02	0.004	6.16	3.01	0.03	0.041	− 5.84	2.83	0.03	0.004	NS
Drug use disorder	− 8.66	1.36	− 0.04	<0.001	− 9.99	3.53	0.04	0.005	− 8.70	3.19	0.04	<0.001	NS
Personality disorder	NS				− 12.57	6.17	− 0.02	0.042	NS				NS
Disability rating %	0.50	0.13	0.02	<0.001	NS				NS				NS
Age	0.09	0.05	0.01	0.039	NS				NS				0.48	0.19	0.04	0.012
PCL scores
PCL re-experiencing	NS				NS				NS				NS
PCL avoidant	− 0.98	0.38	− 0.02	0.009	NS				NS				NS
PCL numbing	NS				NS				NS				NS
PCL dysphoric arousal	NS				NS				NS				NS
PCL anxious arousal	NS				NS				NS				NS

B, unstandardised coefficients; β, standardised coefficients.

NS, not significant.